The effect of carbonyl-binding agents on the potassium-evoked release of [3H] catecholamines from brain and peripheral tissues.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003042:Cocaine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D006321:Heart / Q000187:drug effects; D006898:Hydroxylamines / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D009778:Occipital Lobe / Q000187:drug effects / Q000378:metabolism; D010659:Phenylhydrazines / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology*; D051381:Rats; D013363:Submandibular Gland / Q000187:drug effects / Q000378:metabolism; D013447:Sulfites / Q000494:pharmacology*
D006898:Hydroxylamines; D010659:Phenylhydrazines; D013447:Sulfites; D000255:Adenosine Triphosphate; D003042:Cocaine; D011188:Potassium; D009638:Norepinephrine